Sanofi announces that it has successfully priced its offering of EUR 1.5 billion of notes across 2 tranches: • €850 million floating rate notes, due March 2027, bearing interest at 3-month Euribor ...

Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and ...

Flovie Martins joins Ujjivan Small Finance Bank as head of corporate communications. Prior to this, Martins was working with ...

Global commodity trader Cargill plans to add 500 jobs to its global capability centres (GCCs) in the next two to three years, ...

Quoted Finnish pharmaceutical company Orion Corporation is establishing a new research & development centre in Cambridge to ...

Versatope Therapeutics Incorporated, a biotechnology company developing vaccines and immuno-therapeutics announced today ...

Immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics, discusses the promise of harnessing natural killer cells to reshape treatment for cancer and autoimmune disease.

Earlier in her career, she was an Associate Principal at McKinsey & Company ... Prior to his time at Intercept, Mr. Durso spent over two decades at Sanofi, where he held multiple senior leadership ...

Key Innovations and 5 Companies to Watch in 2025Artificial intelligence is everywhere in 2024, changing industries and ...

Sanofi has made an interesting choice for its ... medicines from discovery to market," alluding to a long career in biopharma that has included founding roles in Alchemab Therapeutics, Dualitas ...

Dr. Mukesh Kumar Dr Mukesh with experience of leading Clinical Development in Sanofi, Daiichi, Cipla, DRL, Lupin, joins CLINEXEL a ...

Bar-Joseph brings extensive expertise from Sanofi, a leading global pharmaceutical company. As the VP and Head of R&D Data and Computational Sciences, he led multidisciplinary teams in machine ...